Extra Super P-Force: Comprehensive Evidence-Based Monograph for the Management of Erectile Dysfunction and Premature Ejaculation

Introduction: Understanding Extra Super P-Force and Its Role in Dual-Indication Therapy Extra Super P-Force represents a fixed-dose combination product containing sildenafil citrate (100 mg) and dapoxetine hydrochloride (60 mg). This formulation addresses two distinct but frequently comorbid male sexual dysfunctions: erectile dysfunction (ED) and premature ejaculation (PE). The product sits at an interesting intersection in sexual medicine—it’s not FDA-approved in this fixed combination, but it’s widely prescribed in several Asian, Middle Eastern, and Eastern European markets where regulatory frameworks differ.